Concurrent therapy with other Investigational Products.
Treatment with any investigational products within 14 days before the first dose of protocol-indicated treatment
Treatment with any investigational products within 28 days prior to study registration
Treatment with any investigational products within 2 weeks before administration of the first dose of the study drugs.
Treatment with any investigational products within 30 days before randomization.
Treatment with any investigational products within 14 days before the first dose of study drug
Treatment with any investigational products within 4 weeks before the first dose of study drug.
Treatment with any investigational products within 14 days before the first dose of any study drug
Previous treatment with venetoclax and/or current participation in any other research study with investigational products.
Concurrent therapy with other investigational products
Treatment with any investigational products within 14 days before the first dose of any study drug
Treatment with any investigational products within 14 days before the first dose of study drug
Treatment with any investigational products within 3 weeks before the first dose of study drug
Treatment with any investigational products within 3 weeks before the first dose of study drug
Previous treatment with any substrate of CYP2B6 enzyme < 14 days prior to initiation of investigational products
Treatment with any investigational products within 4 weeks before the first dose of any study drug
Treatment with any investigational products within 28 days prior to study registration
Treatment with other investigational products within the last 2 months prior to entry into this study
Treatment with any anti leukemic/anti MDS therapies (eg, lenalidomide, cytarabine, anthracyclines, purine analogs) or with any investigational products within 14 days before the first dose of any study drug.
Not be allergic to tomatoes or tomato products
Treatment with any investigational products within 14 days before the first dose of study drug and systemic anticancer therapy within 28 days before the first dose of study drug.
Treatment with any investigational products within 60 days before the first dose of the study drug regimen.
Received radiation therapy =< 14 days prior to initiation of investigational products
Treatment with any investigational products within 4 weeks before the first dose of any study drug
Treatment with any investigational products within 30 days before the first dose of study drug
Treatment with any investigational products within 60 days before the first dose of the study drug regimen
Treatment with any anticancer therapy or any investigational products within 3 weeks before the first dose of study drug.
Treatment with any systemic antineoplastic therapy or investigational products within 21 days before the first dose of study treatment.
Treatment with any investigational products 21 days prior to treatment
Treatment with any investigational products
Exposure to more than 4 investigational medicinal products within 12 months prior to the first dose of study treatment
Investigational products or therapy other than ASP8273
Therapy with any investigational products within 21 days before the first dose of study drug
Abstention from meat and other animal products
Not be allergic to tomato or tomato products
Allergic to fish products
Received other investigational products or therapy in the 60 days prior to study drug administration.
